Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-25 @ 1:37 AM
Ignite Modification Date:
2025-12-25 @ 11:53 PM
NCT ID:
NCT00299494
Group ID:
EG004
Title:
Inotuzumab Ozogamicin MTD + Rituximab 375 mg/m^2 DLBCL
Description:
Participants received the MTD determined in the dose escalation phase; MTD determination in the dose escalation phase was based on toxicities during the 1st cycle. Participants with DLBCL received rituximab 375 mg/m\^2 via IV infusion on Day 1 and the MTD of inotuzumab ozogamicin (1.8 mg/m\^2) via IV infusion on Day 2 of each 28-day cycle for up to 8 cycles unless there was evidence of progressive disease, unacceptable toxicity, or the subject refused further treatment.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
12
Serious Number At Risk:
40
Other Number Affected:
39
Other Number At Risk:
40
Study:
NCT00299494
Results Section:
NCT00299494
Adverse Events Module:
NCT00299494